TY - JOUR
T1 - Prevalence of diabetic retinopathy in adult Chinese American individuals
T2 - The Chinese American eye study
AU - for the Chinese American Eye Study Group
AU - Varma, Rohit
AU - Wen, Ge
AU - Jiang, Xuejuan
AU - Hsu, Chunyi
AU - Torres, Mina
AU - Klein, Ronald
AU - Azen, Stanley P.
AU - McKean-Cowdin, Roberta
AU - Dinh, David
AU - Jiang, Ruzhang
AU - Sun, Jie
AU - Wang, Dandan
AU - Wang, Yu Ping
AU - Wong, Justine
AU - Wu, Shuang
AU - Desai, Rucha
AU - John, Lisa V.
AU - Cheng, Michelle
AU - Meuer, Stacy M.
AU - Sommer, Alfred
AU - Coleman, Anne
AU - Han, Dennis
AU - Hanis, Craig
AU - Wideroff, Louise
AU - Young, Terri
N1 - Funding Information:
Funding/Support: This work was supported by grant EY-017337 from the National Eye Institute of the National Institutes of Health and by an unrestricted departmental grant from Research to Prevent Blindness.
Publisher Copyright:
Copyright 2016 American Medical Association. All rights reserved.
PY - 2016/5
Y1 - 2016/5
N2 - IMPORTANCE Chinese American individuals are a fast-growing segment of people in the United States, but the burden and effect of diabetic complications on this group of people is not fully understood. OBJECTIVE To determine the age- and sex-specific prevalence of diabetic retinopathy (DR) overall and by severity, duration of diabetes, and treatment history in adult Chinese American individuals. DESIGN, SETTING, AND PARTICIPANTS The Chinese American Eye Study (CHES), a population-based, cross-sectional study, was conducted from February 2010 to October 2013 for 10 census tracts in Monterey Park, California. This analysis, conducted between February 16, 2010, and October 9, 2013, included 4582 Chinese residents 50 years and older. MAIN OUTCOMES AND MEASURES Prevalence of nonproliferative DR, proliferative DR, and macular edema, as well as stereoscopic fundus photography of 7 standard Early Treatment Diabetic Retinopathy Study fields. RESULTS Of the 4582 survey participants, most were first-generation immigrants from China (68.7%) and female (63%). In total, 736 participants (16.1%) were identified as having type 2 diabetes. Fundus photographs were gradable for 665 (90.4%) of these participants. The reproducibility of DR grading was evaluated throughout study and showed moderate to excellent agreement (weighted ê = 0.78-0.97). Diabetic retinopathy was present in 35.8% of people with diabetes (95%CI, 32.1%-39.6%). The estimated prevalence of severe nonproliferative DR and proliferative DR was 1.7%(95%CI, 0.8%-2.9%) and 2.4%(95%CI, 1.4%-3.9%), respectively. Macular edema was observed among 4.5%of people with diabetes (95%CI, 3.0%-6.4%), and clinically significant macular edema was observed among 2.0% (95%CI, 1.1%-3.3%). The prevalence of DR was higher (56%) among participants with a longer duration of diabetes (15 years; P < .001). The prevalence of visual impairment (best-corrected visual acuity worse than 20/40 in the better-seeing eye) among participants with diabetes was higher than those without diabetes (6.7%vs 2.2% = difference of 4.5%; 95%CI, 3.9%-5.1%). The primary causes of visual impairment in participants with diabetes were cataracts (38%of participants; 95%CI, 36.6%-39.4%) followed by macular edema (7% of participants; 95%CI, 6.3%-7.7%). CONCLUSIONS AND RELEVANCE Data from CHES and this study indicate that the prevalence of DR in the Chinese American Eye Study Group is relatively lower than studies of Chinese individuals residing in rural northern China or Latino individuals from Los Angeles County, California.
AB - IMPORTANCE Chinese American individuals are a fast-growing segment of people in the United States, but the burden and effect of diabetic complications on this group of people is not fully understood. OBJECTIVE To determine the age- and sex-specific prevalence of diabetic retinopathy (DR) overall and by severity, duration of diabetes, and treatment history in adult Chinese American individuals. DESIGN, SETTING, AND PARTICIPANTS The Chinese American Eye Study (CHES), a population-based, cross-sectional study, was conducted from February 2010 to October 2013 for 10 census tracts in Monterey Park, California. This analysis, conducted between February 16, 2010, and October 9, 2013, included 4582 Chinese residents 50 years and older. MAIN OUTCOMES AND MEASURES Prevalence of nonproliferative DR, proliferative DR, and macular edema, as well as stereoscopic fundus photography of 7 standard Early Treatment Diabetic Retinopathy Study fields. RESULTS Of the 4582 survey participants, most were first-generation immigrants from China (68.7%) and female (63%). In total, 736 participants (16.1%) were identified as having type 2 diabetes. Fundus photographs were gradable for 665 (90.4%) of these participants. The reproducibility of DR grading was evaluated throughout study and showed moderate to excellent agreement (weighted ê = 0.78-0.97). Diabetic retinopathy was present in 35.8% of people with diabetes (95%CI, 32.1%-39.6%). The estimated prevalence of severe nonproliferative DR and proliferative DR was 1.7%(95%CI, 0.8%-2.9%) and 2.4%(95%CI, 1.4%-3.9%), respectively. Macular edema was observed among 4.5%of people with diabetes (95%CI, 3.0%-6.4%), and clinically significant macular edema was observed among 2.0% (95%CI, 1.1%-3.3%). The prevalence of DR was higher (56%) among participants with a longer duration of diabetes (15 years; P < .001). The prevalence of visual impairment (best-corrected visual acuity worse than 20/40 in the better-seeing eye) among participants with diabetes was higher than those without diabetes (6.7%vs 2.2% = difference of 4.5%; 95%CI, 3.9%-5.1%). The primary causes of visual impairment in participants with diabetes were cataracts (38%of participants; 95%CI, 36.6%-39.4%) followed by macular edema (7% of participants; 95%CI, 6.3%-7.7%). CONCLUSIONS AND RELEVANCE Data from CHES and this study indicate that the prevalence of DR in the Chinese American Eye Study Group is relatively lower than studies of Chinese individuals residing in rural northern China or Latino individuals from Los Angeles County, California.
UR - http://www.scopus.com/inward/record.url?scp=84968754737&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84968754737&partnerID=8YFLogxK
U2 - 10.1001/jamaophthalmol.2016.0445
DO - 10.1001/jamaophthalmol.2016.0445
M3 - Article
C2 - 27055063
AN - SCOPUS:84968754737
SN - 2168-6165
VL - 134
SP - 563
EP - 569
JO - JAMA Ophthalmology
JF - JAMA Ophthalmology
IS - 5
ER -